Copyright Reports & Markets. All rights reserved.

Global Inhaled Generic Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Inhaled Generic Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 DPI
    • 1.3.3 MDI
    • 1.3.4 NEB
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Inhaled Generic Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Asthma
    • 1.4.3 COPD
    • 1.4.4 Inhalation Anesthesia
    • 1.4.5 Others
  • 1.5 Global Inhaled Generic Drugs Market Size & Forecast
    • 1.5.1 Global Inhaled Generic Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Inhaled Generic Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Inhaled Generic Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Inhaled Generic Drugs Product and Services
    • 2.1.4 GSK Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca Inhaled Generic Drugs Product and Services
    • 2.2.4 AstraZeneca Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AstraZeneca Recent Developments/Updates
  • 2.3 Boehringer-Ingelheim
    • 2.3.1 Boehringer-Ingelheim Details
    • 2.3.2 Boehringer-Ingelheim Major Business
    • 2.3.3 Boehringer-Ingelheim Inhaled Generic Drugs Product and Services
    • 2.3.4 Boehringer-Ingelheim Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boehringer-Ingelheim Recent Developments/Updates
  • 2.4 CTTQ
    • 2.4.1 CTTQ Details
    • 2.4.2 CTTQ Major Business
    • 2.4.3 CTTQ Inhaled Generic Drugs Product and Services
    • 2.4.4 CTTQ Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 CTTQ Recent Developments/Updates
  • 2.5 Sphsine
    • 2.5.1 Sphsine Details
    • 2.5.2 Sphsine Major Business
    • 2.5.3 Sphsine Inhaled Generic Drugs Product and Services
    • 2.5.4 Sphsine Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sphsine Recent Developments/Updates
  • 2.6 Daphne Pharmaceutical
    • 2.6.1 Daphne Pharmaceutical Details
    • 2.6.2 Daphne Pharmaceutical Major Business
    • 2.6.3 Daphne Pharmaceutical Inhaled Generic Drugs Product and Services
    • 2.6.4 Daphne Pharmaceutical Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Daphne Pharmaceutical Recent Developments/Updates
  • 2.7 Jewim Pharmaceutical
    • 2.7.1 Jewim Pharmaceutical Details
    • 2.7.2 Jewim Pharmaceutical Major Business
    • 2.7.3 Jewim Pharmaceutical Inhaled Generic Drugs Product and Services
    • 2.7.4 Jewim Pharmaceutical Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Jewim Pharmaceutical Recent Developments/Updates
  • 2.8 CF PharmTech
    • 2.8.1 CF PharmTech Details
    • 2.8.2 CF PharmTech Major Business
    • 2.8.3 CF PharmTech Inhaled Generic Drugs Product and Services
    • 2.8.4 CF PharmTech Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 CF PharmTech Recent Developments/Updates
  • 2.9 Xianju Pharmaceutical
    • 2.9.1 Xianju Pharmaceutical Details
    • 2.9.2 Xianju Pharmaceutical Major Business
    • 2.9.3 Xianju Pharmaceutical Inhaled Generic Drugs Product and Services
    • 2.9.4 Xianju Pharmaceutical Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Xianju Pharmaceutical Recent Developments/Updates
  • 2.10 Joincare Pharmaceutical
    • 2.10.1 Joincare Pharmaceutical Details
    • 2.10.2 Joincare Pharmaceutical Major Business
    • 2.10.3 Joincare Pharmaceutical Inhaled Generic Drugs Product and Services
    • 2.10.4 Joincare Pharmaceutical Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Joincare Pharmaceutical Recent Developments/Updates
  • 2.11 Hengrui Medicine
    • 2.11.1 Hengrui Medicine Details
    • 2.11.2 Hengrui Medicine Major Business
    • 2.11.3 Hengrui Medicine Inhaled Generic Drugs Product and Services
    • 2.11.4 Hengrui Medicine Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hengrui Medicine Recent Developments/Updates
  • 2.12 Purity Pharmaceutical
    • 2.12.1 Purity Pharmaceutical Details
    • 2.12.2 Purity Pharmaceutical Major Business
    • 2.12.3 Purity Pharmaceutical Inhaled Generic Drugs Product and Services
    • 2.12.4 Purity Pharmaceutical Inhaled Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Purity Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Inhaled Generic Drugs by Manufacturer

  • 3.1 Global Inhaled Generic Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Inhaled Generic Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Inhaled Generic Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Inhaled Generic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Inhaled Generic Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Inhaled Generic Drugs Manufacturer Market Share in 2025
  • 3.5 Inhaled Generic Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Inhaled Generic Drugs Market: Region Footprint
    • 3.5.2 Inhaled Generic Drugs Market: Company Product Type Footprint
    • 3.5.3 Inhaled Generic Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Inhaled Generic Drugs Market Size by Region
    • 4.1.1 Global Inhaled Generic Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Inhaled Generic Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Inhaled Generic Drugs Average Price by Region (2021-2032)
  • 4.2 North America Inhaled Generic Drugs Consumption Value (2021-2032)
  • 4.3 Europe Inhaled Generic Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Inhaled Generic Drugs Consumption Value (2021-2032)
  • 4.5 South America Inhaled Generic Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Inhaled Generic Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Inhaled Generic Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Inhaled Generic Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Inhaled Generic Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Inhaled Generic Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Inhaled Generic Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Inhaled Generic Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Inhaled Generic Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Inhaled Generic Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Inhaled Generic Drugs Market Size by Country
    • 7.3.1 North America Inhaled Generic Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Inhaled Generic Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Inhaled Generic Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Inhaled Generic Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Inhaled Generic Drugs Market Size by Country
    • 8.3.1 Europe Inhaled Generic Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Inhaled Generic Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Inhaled Generic Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Inhaled Generic Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Inhaled Generic Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Inhaled Generic Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Inhaled Generic Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Inhaled Generic Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Inhaled Generic Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Inhaled Generic Drugs Market Size by Country
    • 10.3.1 South America Inhaled Generic Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Inhaled Generic Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Inhaled Generic Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Inhaled Generic Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Inhaled Generic Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Inhaled Generic Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Inhaled Generic Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Inhaled Generic Drugs Market Drivers
  • 12.2 Inhaled Generic Drugs Market Restraints
  • 12.3 Inhaled Generic Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Inhaled Generic Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Inhaled Generic Drugs
  • 13.3 Inhaled Generic Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Inhaled Generic Drugs Typical Distributors
  • 14.3 Inhaled Generic Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Inhaled Generic Drugs market size was valued at US$ 692 million in 2025 and is forecast to a readjusted size of US$ 982 million by 2032 with a CAGR of 5.2% during review period.
    Inhalation preparation is a special dosage form that is administered through the lungs. It can quickly and directly enter the lungs to exert drug effects through local administration, reducing the dosage and improving the efficacy of the drug. This report mainly focuses on inhaled generic drugs market.
    Inhaled drug delivery has the advantages of fast onset of action, rapid absorption, and few side effects. From the perspective of global mature markets, inhaled drug delivery is the mainstream treatment drug for respiratory diseases and the competitive landscape is relatively stable. There is great clinical demand in the field of inhaled formulations for asthma and COPD. China"s market for asthma and inhaled preparations has broad prospects, and the rise of Chinese pharmaceutical companies is expected to come as China"s domestic generic varieties are launched one after another.
    This report is a detailed and comprehensive analysis for global Inhaled Generic Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Inhaled Generic Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Inhaled Generic Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Inhaled Generic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Inhaled Generic Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Inhaled Generic Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Inhaled Generic Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, AstraZeneca, Boehringer-Ingelheim, CTTQ, Sphsine, Daphne Pharmaceutical, Jewim Pharmaceutical, CF PharmTech, Xianju Pharmaceutical, Joincare Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Inhaled Generic Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    DPI
    MDI
    NEB
    Market segment by Application
    Asthma
    COPD
    Inhalation Anesthesia
    Others
    Major players covered
    GSK
    AstraZeneca
    Boehringer-Ingelheim
    CTTQ
    Sphsine
    Daphne Pharmaceutical
    Jewim Pharmaceutical
    CF PharmTech
    Xianju Pharmaceutical
    Joincare Pharmaceutical
    Hengrui Medicine
    Purity Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Inhaled Generic Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Inhaled Generic Drugs, with price, sales quantity, revenue, and global market share of Inhaled Generic Drugs from 2021 to 2026.
    Chapter 3, the Inhaled Generic Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Inhaled Generic Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Inhaled Generic Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Inhaled Generic Drugs.
    Chapter 14 and 15, to describe Inhaled Generic Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now